"Nvidia's $50 Million Investment Sends Recursion Stock Skyrocketing in AI Drug Discovery"

Nvidia has invested $50 million in biotech company Recursion Pharmaceuticals to support its AI-driven drug discovery efforts, causing Recursion's stock to soar. The investment will help Recursion accelerate the development of new drugs using artificial intelligence and machine learning technologies.